Health Insurance Innovations (HIIQ) versus Its Competitors Critical Contrast

Share on StockTwits

Health Insurance Innovations (NASDAQ: HIIQ) is one of 19 public companies in the “Insurance agents, brokers, & service” industry, but how does it weigh in compared to its competitors? We will compare Health Insurance Innovations to similar businesses based on the strength of its analyst recommendations, valuation, dividends, profitability, institutional ownership, earnings and risk.

Profitability

This table compares Health Insurance Innovations and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Health Insurance Innovations 4.49% 28.34% 14.41%
Health Insurance Innovations Competitors 7.10% 18.06% 9.00%

Earnings & Valuation

This table compares Health Insurance Innovations and its competitors gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Health Insurance Innovations $351.10 million $12.99 million 16.11
Health Insurance Innovations Competitors $13.74 billion $1.05 billion 34.26

Health Insurance Innovations’ competitors have higher revenue and earnings than Health Insurance Innovations. Health Insurance Innovations is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

60.5% of shares of all “Insurance agents, brokers, & service” companies are held by institutional investors. 55.9% of Health Insurance Innovations shares are held by insiders. Comparatively, 20.3% of shares of all “Insurance agents, brokers, & service” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Health Insurance Innovations and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health Insurance Innovations 0 0 6 1 3.14
Health Insurance Innovations Competitors 185 677 765 39 2.39

Health Insurance Innovations currently has a consensus target price of $61.71, indicating a potential upside of 108.14%. As a group, “Insurance agents, brokers, & service” companies have a potential upside of 3.78%. Given Health Insurance Innovations’ stronger consensus rating and higher probable upside, analysts plainly believe Health Insurance Innovations is more favorable than its competitors.

Volatility and Risk

Health Insurance Innovations has a beta of 1.79, indicating that its share price is 79% more volatile than the S&P 500. Comparatively, Health Insurance Innovations’ competitors have a beta of 0.85, indicating that their average share price is 15% less volatile than the S&P 500.

Summary

Health Insurance Innovations beats its competitors on 8 of the 13 factors compared.

About Health Insurance Innovations

Health Insurance Innovations, Inc. operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. It offers short-term medical plans that provide three months of health insurance coverage with various deductible and copay levels; health benefit insurance plans, which offer daily cash benefit for hospital treatment and doctor office visits, as well as accidental injury and death or dismemberment benefits; and supplemental insurance products, including pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies. The company designs and structures individual and family health insurance plans, and supplemental products in concert with insurance carriers and discount benefit providers; and markets them to individuals through a network of distributors. Health Insurance Innovations, Inc. was founded in 2008 and is based in Tampa, Florida.

Receive News & Ratings for Health Insurance Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Forterra  Raised to “Hold” at Zacks Investment Research
Forterra Raised to “Hold” at Zacks Investment Research
Morgan Stanley Raises Public Service Enterprise Group  Price Target to $69.00
Morgan Stanley Raises Public Service Enterprise Group Price Target to $69.00
Campbell Soup  Stock Rating Reaffirmed by Bank of America
Campbell Soup Stock Rating Reaffirmed by Bank of America
Zacks Investment Research Lowers Fortune Brands Home & Security  to Hold
Zacks Investment Research Lowers Fortune Brands Home & Security to Hold
Stanley Black & Decker  Upgraded to “Buy” by Zacks Investment Research
Stanley Black & Decker Upgraded to “Buy” by Zacks Investment Research
LCI Industries  Coverage Initiated at Northcoast Research
LCI Industries Coverage Initiated at Northcoast Research


© 2006-2019 Ticker Report